Clinical Study

Evaluation of Rhubarb Supplementation in Stages 3 and 4 of Chronic Kidney Disease: A Randomized Clinical Trial

Table 1

Blood pressure in control and Rhubarb groups before and after 12 weeks of treatment.

Serial numberParameterGroup0 week
mean ± SD
12 weeks
mean ± SD
% change after 12 weeks95% confidence interval

1SBP (mm Hg)I150.40 ± 17.62136.62 ± 16.45b(−) 9.16%22.81 to 32.90
II152.97 ± 20.60132.60 ± 8.79b1(−) 13.31%31.93 to 44.30

2DBP (mm Hg)I87.32 ± 10.4385.98 ± 9.65(−) 1.53%12.43 to 22.92
II88.02 ± 12.4084.73 ± 9.31b1(−) 4.40%12.97 to 23.30

Values are mean ± SD; was considered significant; b compared to 0 week value of respective group; 1 compared to control group. I: Control; II: Rhubarb; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; (−) decrease.